KU Leuven researchers identify promising drug for treating severe malaria
Researchers at the Rega Institute – KU Leuven have reported promising results using ruxolitinib to treat severe malaria. The study, conducted in mice, shows that the drug prevents both inflammation and life-threatening hypoglycaemia, two disease processes …